Key facts
- This page summarizes Alison Bauerlein's Form 4/A - Amendment filing for Inogen Inc (INGN).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Dec 2021, 17:10.
Alison Bauerlein - 15 Dec 2020 Form 4/A - Amendment Insider Report for Inogen Inc (INGN)
- Reporting relationship
- EVP, Finance, & CFO
- Issuer ticker
- INGN
- Reported as of
- 15 Dec 2020
- Net transaction value
- -$204,881
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 03 Dec 2021, 17:10:25 UTC
- Original report date
- 16 Dec 2020
- Next SEC filing
- 03 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alison Bauerlein
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alison Bauerlein filed Form 4/A - Amendment for Inogen Inc (INGN) on 03 Dec 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$204,881.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INGN
transaction
Common Stock
Options Exercise
- Transaction value
- $144,627
- Shares
- +8,702
- Change %
- +27%
- Price
- $16.62
- Shares after
- 41,172
- Date
- 15 Dec 2020
- Ownership
- Direct
- Footnotes
- F1
INGN
transaction
Common Stock
Sale
- Transaction value
- $175,464
- Shares
- -4,449
- Change %
- -11%
- Price
- $39.44
- Shares after
- 36,723
- Date
- 15 Dec 2020
- Ownership
- Direct
- Footnotes
- F2, F3, F4
INGN
transaction
Common Stock
Sale
- Transaction value
- $76,960
- Shares
- -1,904
- Change %
- -5.2%
- Price
- $40.42
- Shares after
- 34,819
- Date
- 15 Dec 2020
- Ownership
- Direct
- Footnotes
- F2, F5, F6
INGN
transaction
Common Stock
Sale
- Transaction value
- $97,084
- Shares
- -2,349
- Change %
- -6.7%
- Price
- $41.33
- Shares after
- 32,470
- Date
- 15 Dec 2020
- Ownership
- Direct
- Footnotes
- F2, F7, F8
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INGN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -8,702
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 15 Dec 2020
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,702
- Exercise price
- $16.62
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Originally filed Form 4 reported 11,017.
Footnote F2
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.
Footnote F3
Represents the weighted average share price of an aggregate total of 4,449 shares sold in the price range of $39.01 to $39.92 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F4
Originally filed Form 4 reported 6,568.
Footnote F5
Represents the weighted average share price of an aggregate total of 1,904 shares sold in the price range of $40.18 to $40.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F6
Originally filed Form 4 reported 4,664.
Footnote F7
Represents the weighted average share price of an aggregate total of 2,349 shares sold in the price range of $41.00 to $41.50 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F8
Originally filed Form 4 reported 2,315.
Footnote F9
Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is April 1, 2014. This option was fully vested as of April 1, 2018.